Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial

Eighty-seven CAPD patients whose hematocrit (Ht) level was maintained by recombinant human erythropoietin (rHuEPO) were enrolled in this trial for a new formulation of rHuEPO suitable for subcutaneous injection. 6000IU rHuEPO was administered every 2 weeks for 12 weeks. Fortnightly doses were increa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nihon Jinzo Gakkai shi 1993-09, Vol.35 (9), p.1081-1090
Hauptverfasser:	Kubota, M, Kawaguchi, Y, Nomoto, Y, Tsuchida, H, Nihei, H, Kubo, K, Omori, Y, Babazono, T, Ogura, Y, Hara, S
Format:	Artikel
Sprache:	eng ; jpn
Schlagworte:	Adult Aged Anemia - etiology Anemia - therapy Drug Administration Schedule Erythropoietin - administration & dosage Female Humans Injections, Subcutaneous Japan Male Middle Aged Peritoneal Dialysis, Continuous Ambulatory - adverse effects Recombinant Proteins - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!